Adherex Technologies (FENC)
(Delayed Data from NSDQ)
$6.61 USD
+0.04 (0.61%)
Updated Jul 25, 2024 04:00 PM ET
3-Hold of 5 3
B Value A Growth C Momentum A VGM
Brokerage Reports
Adherex Technologies Inc. [FENC]
Reports for Purchase
Showing records 61 - 80 ( 106 total )
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
From Underneath The Rubble Sing a Rebel Song
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Patent Protection Prolongs PEDMARK Potential
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Sodium Thiosulfate Application Accepted for Review in Europe; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
2019 Financials Reported; PEDMARK Approval Decision Approaching; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
FY19 Financials; Awaiting FDA Action Following NDA Submission
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
PEDMARK Regulatory Submission Complete; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
PEDMARK Rolling NDA Submission Complete; Approval Anticipated in Q3:20
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Application Submission Nearing Completion; 3Q19 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
HEALTHCARE - 2019 PacGrow Healthcare Conference: Day 2 Recap
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
2Q19 Financial Results Reported; PEDMARK Regulatory Submission Completion in Early 2020; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
1Q19 Financial Results Reported; PEDMARK Filing Completion Near Term; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
FY18; Manufacturing Hiccup to Delay NDA Approval, but Opportunity Unchanged
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
FY2018 Financial Results Reported; PEDMARK Filing Timeline Update; Modulating Target to $17
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R